Key result
Individualized pharmaceutical care at the workplace reduced mean systolic and diastolic blood pressure and improved medication adherence among hypertensive staff.
Why the study?
Improper management of hypertension reduces productivity, with poor adherence and inadequate care contributing to ineffective therapy. The study sought to ascertain the effectiveness of workplace pharmaceutical care on adherence and blood pressure control.
Does individualized pharmaceutical care at the workplace improve blood pressure control and medication adherence in hypertensive staff?
Does individualized pharmaceutical care at the workplace improve blood pressure control and medication adherence in hypertensive staff?
Workplace-based pharmaceutical care significantly improves blood pressure control and medication adherence among hypertensive employees.
Answers are grounded in this paper and cite their sources.
Workplace pharmaceutical care was associated with better BP control and adherence; hypothesis-generating and requires randomized confirmation before practice change.
Several hours of productivity are lost due to improper management of hypertension. Poor adherence and inadequate care due to weak healthcare systems contribute to the lack of effectiveness of anti-hypertensive therapy. Pharmaceutical care plays a vital role in achieving treatment goals for patients with chronic conditions such as hypertension. This study sought to ascertain the effectiveness of pharmaceutical care services provided at the workplace on adherence and blood pressure control among staff with hypertension. This was a prospective pre-post study conducted at the Kwame Nkrumah University of Science and Technology from September 2019 to September 2020. Staff with confirmed diagnosis of hypertension were offered individualized pharmaceutical care every month for six months. Outcome measures were changes in blood pressure measurement , adherence and the number of pharmaceutical care issues identified and resolved. Forty-three university staff participated in this study. Reductions in mean systolic and diastolic blood pressure and difference in mean adherence scores were statistically significant after 6 months of follow up ( p ≤ 0.00). A medical diagnosis of diabetes ( p ≤ 0.044) and Body Mass Index ( p ≤ 0.038) were associated with control of hypertension. Adherence to medications improved after the follow up period. Participants and pharmacists involved in the study expressed satisfaction with the program's impact . Pharmaceutical care at the workplace can improve medication adherence and blood pressure control among hypertensive patients. Blood pressure control was also better among individuals with normal Body Mass Index or a medical history of diabetes.
No takes yet. Share an insight, caveat, or question.
Mozu et al. (2021) studied hypertension (n=43). Individualized pharmaceutical care vs. Baseline (pre-intervention) was evaluated on changes in blood pressure measurement, adherence and the number of pharmaceutical care issues identified and resolved (p=≤ 0.00). Individualized pharmaceutical care at the workplace reduced mean systolic and diastolic blood pressure and improved medication adherence among hypertensive staff.
Synapse has enriched 10 related papers. Consider them for comparative context: